Evaluating and discerning talent at the quarterback position in the NFL is long and arduous, and not surprisingly, as nailing the player you place at the helm can often make the difference between a ...
SAN FRANCISCO--(BUSINESS WIRE)--Atomwise announced today results from the AIMS (Artificial Intelligence Molecular Screen) initiative that establish the AtomNet AI Platform as a viable alternative to ...
The TRITON study is evaluating tremelimumab/durvalumab/chemotherapy vs pembrolizumab/chemotherapy in non–small lung cancer (NSCLC) with STK11 and/or KEAP1 and/or ...
SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world evidence of the effectiveness of a treat-to-target (T2T) ...
BofA Securities has upgraded Fulcrum Therapeutics (NASDAQ:FULC) ahead of the company’s phase 3 losmapimod readout, expected by the end of October for Facioscapulohumeral muscular dystrophy (FSHD).
Hard work and sacrifice lead to success, and happiness is by-product. In its most productive form, living in a dynamic of ...
Surmodics (SRDX) announced that results from an analysis of 160 real-world patients with symptomatic infrainguinal limb ischemia from its PROWL ...
Researchers have successfully used repurposed cancer drugs to target dormant breast cancer cells, aiding in the delay or prevention of recurrence, according to a study published Sept. 2 in Nature ...
CLEVELAND—Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease, is an incurable neurological disorder affecting motor neurons—nerve cells in the brain and spinal cord that control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback